Fact CheckerSign in

NCT04091204RecruitingPhase 2

MITO 31- A phase II trial of Olaparib in patients with recurrent ovarian cancer wild type for germline and somatic BRCA 1 and 2 genes: The MITO 31 translational study.

Source: EU CTIS (euclinicaltrials.eu) · Last updated 20 Apr 2026

Brief summary (registry, in English)

Primary Objective - To explore a prognostic clinical and molecular biomarker profile in a population of BRCA wild-type recurrent high-grade ovarian cancer patients treated with olaparib as maintenance after response to a platinum based therapy as platinum sensitive recurrence treatment.

Status (registry)
Recruiting
Phase (registry)
Phase 2
Study type
Interventional
Enrollment
100 (estimated)
First submitted
25 Nov 2024
Start date
9 Jan 2025
Lead sponsor
IRCCS Istituto Nazionale Tumori Fondazione Pascale
NCT number
NCT04091204
EU CT number
2024-516841-38-00
EudraCT number
2018-000617-20

What you commit to

  • Study type: Interventional · Phase 2
  • Planned participants: 100
  • 19 sites in 1 country
  • Visits and tests: ask the trial team, the registry does not list them

Built from the registry fields of EU CTIS (euclinicaltrials.eu). It describes the study, not your situation.

Who cannot take part

Copied verbatim from EU CTIS (euclinicaltrials.eu) and grouped by topic. Only the trial team decides who can take part.

Age in the registry: 18 years to - · Sex: Female · Does not accept healthy volunteers

Full criteria on EU CTIS (euclinicaltrials.eu)

Sites (19)

Sites in registry order. Pick your city on the disease page to sort them by distance.

SiteCityCountrySite status
AORN San Giuseppe Moscati Avellino
Coordinator of this site? Confirm its status
AvellinoItalyRecruiting
Centro di Riferimento Oncologico di Aviano
Coordinator of this site? Confirm its status
AvianoItalyRecruiting
UOC ONCOLOGIA MEDICA - P.O. "A. PERRINO"
Coordinator of this site? Confirm its status
BrindisiItalyRecruiting
AUSL Modena - Ospedale B. Ramazzini
Coordinator of this site? Confirm its status
CarpiItalyRecruiting
PO Garibaldi-Nesima, ARNAS Garibaldi
Coordinator of this site? Confirm its status
CataniaItalyRecruiting
Azienda Ospedaliero Universitaria Renato Dulbecco
Coordinator of this site? Confirm its status
CatanzaroItalyRecruiting
Ospedale Mater Salutis Di Legnago
Coordinator of this site? Confirm its status
LegnagoItalyRecruiting
Istituto Romagnolo per lo Studio dei Tumori "Dino Amadori" - IRST S.r.l
Coordinator of this site? Confirm its status
MeldolaItalyRecruiting
Fondazione IRCCS Cà Granda Ospedale Maggiore Policlinico
Coordinator of this site? Confirm its status
MilanItalyRecruiting
Istituto San Raffaele
Coordinator of this site? Confirm its status
MilanItalyRecruiting
Azienda Ulss n.3 Serenissima – Ospedale di Mirano
Coordinator of this site? Confirm its status
MiranoItalyRecruiting
IRCCS Istituto Nazionale Tumori Fondazione Pascale
Coordinator of this site? Confirm its status
NaplesItalyRecruiting
Grande Ospedale Metropolitano Bianchi Melacrino Morelli
Coordinator of this site? Confirm its status
Reggio CalabriaItalyRecruiting
Ospedale "Infermi" di Rimini
Coordinator of this site? Confirm its status
RiminiItalyRecruiting
I.F.O. Istituti Fisioterapici Ospitalieri
Coordinator of this site? Confirm its status
RomeItalyRecruiting
Università Cattolica del Sacro Cuore
Coordinator of this site? Confirm its status
RomeItalyRecruiting
Ospedale Di Sassuolo S.p.A.
Coordinator of this site? Confirm its status
SassuoloItalyRecruiting
Azienda Ospedaliera Universitaria Citta Della Salute E Della Scienza Di Torino
Coordinator of this site? Confirm its status
TurinItalyRecruiting
Ospedale San Bortolo di Vicenza
Coordinator of this site? Confirm its status
VicenzaItalyRecruiting

This page is information, not medical advice. Discuss any trial with your doctor.